Researchers at the Department of Statistics and Applied Probability and the Saw Swee Hock School of Public Health, National University of Singapore are predicting that by 2015, 233 million women across the world will have an unmet need for modern contraceptive methods.
The study evaluated data on 194 countries from the United Nations Population Division database between 1990 and 2010. Overall, the contraceptive use among women of reproductive age increased from 54.8% in 1990 to 63.3% in 2010. Additionally, the unmet need for contraception decreased from 15.4% in 1990 to 12.3% in 2010. Unmet need was defined as women who would like to delay getting pregnant, but were unable to access contraceptive methods.
Birth Control Pills
Oral contraceptive or birth control pills contain hormones that prevent pregnancy. It is one of the most reliable methods of contraception.
Advertisement
Based on the prevalent trends, the researchers predict that the need for contraception will rise from 900 million in 2010 to 962 million in 2015.
"Our findings support calls to increase investments in family planning, especially in regions where contraceptive prevalence is still low, unmet need is high, and the growth in the number of women of reproductive age is rapid," the authors wrote in their report published online on March 12 in the Lancet.
Source: Medindia
Source: Medindia
Birth Control Patch
A birth control patch is a new method of contraception for women for once weekly external application and contains both estrogen and progesterone.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
Cannabis is marketed to women for managing menopause symptoms, and this shows midlife women are using it for menopause and related issues.
A higher risk of preterm birth was found to be associated with inadequate sleep and lower physical activity during pregnancy.
During the 7 pill-free days in contraception, women experience anxiety and mental issues similar to menstrual mood swings.
In the new study, it remains uncertain if the increased expression of the IGF1 gene in PCOS plays a role in elevating the risk of endometrial cancer.
Obese women experience increased severity of menopausal symptoms and reduced effectiveness and relief from hormonal therapy.
